Home / News / Publications

Publications

Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9

Laurenz Pauleikhoff, Tjebo F.C. Heeren, Martin Gliem, Ernest Lim, Daniel Pauleikhoff, Frank G. Holz, Traci Clemons, Konstantinos Balaskas, MACTEL STUDY GROUP, Catherine A. Egan, Peter Charbel Issa. American Journal of Ophthalmology (228):27-34, Aug 1, 2021. DOI:https://doi.org/10.1016/j.ajo.2021.03.022

Morphological characteristics preceding exudative neovascularization secondary to macular telangiectasia type 2

K Hess, PC Issa, FG Holz, S Tzaridis. British Journal of Ophthalmology. Published Online First: 24 June 2021. doi: 10.1136/bjophthalmol-2020-318470

Longitudinal Fluorescence Lifetime Imaging Ophthalmoscopy Analysis in Patients with Macular Telangiectasia type 2 (MacTel)

Sauer, Lydia MD; Vitale, Alexandra S. BS; Modersitzki, Natalie K.; Bernstein, Paul S. MD, PhD. Retina: July 2021 41(7):1416-1427.

Serine biosynthesis defect due to haploinsufficiency of PHGDH causes retinal disease

Kevin Eade, Marin L. Gantner, Joseph A. Hostyk, Takayuki Nagasaki, Sarah Giles, Regis Fallon, Sarah Harkins-Perry, Michelle Baldini, Esther W. Lim, Lea Scheppke, Michael I. Dorrell, Carolyn Cai, Evan H. Baugh, Charles J. Wolock, Martina Wallace, Rebecca B. Berlow, David B. Goldstein, Christian M. Metallo, Martin Friedlander & Rando Allikmets. Nature Metabolism 2, 366-377(2021).

Systemic lipid dysregulation is a risk factor for macular neurodegenerative disease

Roberto Bonelli, Sasha M. Woods, Brendan R. E. Ansell, Tjebo F. C. Heeren, Catherine A. Egan, Kamron N. Khan, Robyn Guymer, Jennifer Trombley, Martin Friedlander, Melanie Bahlo & Marcus Fruttiger

Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area. MacTel Project Report 8.

Tjebo F.C. Heeren, MD, Emily Y. Chew, MD, Traci Clemons, PhD, Catherine A. Egan, FRCOphth, Peter Charbel Issa, FEBO, DPhil, for the MacTel Study Group. Ophthalmology (2020).

Longitudinal Assessment of Remnant Foveal Cone Structure in a Case Series of Early Macular Telangiectasia Type 2

Katie M. Litts; Mali Okada; Tjebo F. C. Heeren; Angelos Kalitzeos; Vincent Rocco; Rebecca R. Mastey; Navjit Singh; Thomas Kane; Melissa Kasilian; Marcus Fruttiger; Michel Michaelides; Joseph Carroll; Catherine Egan. Translational Vision Science and Technology (2020).

Genetic Disruption of Serine Biosynthesis is a Key Driver of Macular Telangiectasia Type 2 Etiology and Progression

Roberto Bonelli, Brendan R E Ansell, Luca Lotta, Thomas Scerri, Traci E Clemons, Irene Leung, The MacTel Consortium, Tunde Peto, Alan C Bird, Ferenc B Sallo, Claudia Langenberg, Melanie Bahlo. bioRxiv, Feb 10, 2020.

Dark Adaptation in Macular Telangiectasia Type 2

Tzaridis, Simone MD; Hess, Kristina MD; Heeren, Tjebo F. C. MD; Nadal, Jennifer; Mai, Clarissa; Herrmann, Philipp MD, PhD; Charbel Issa, Peter MD, DPhil; Holz, Frank G. MD. Retina 2019.

Binocular Inhibition of Reading in Macular Telangiectasia Type 2

Simone Tzaridis; Philipp Herrmann; Peter Charbel Issa; Simona Degli Esposti; Siegfried K Wagner; Marcus Fruttiger; Catherine Egan; Gary Rubin; Frank G. Holz; Tjebo F. C. Heeren. IOVS 2019.

Older Publications